These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28973374)

  • 1. Effects of Intravitreal Dexamethasone Implants on Retinal Oxygen Saturation, Vessel Diameter, and Retrobulbar Blood Flow Velocity in ME Secondary to RVO.
    Eibenberger K; Schmetterer L; Rezar-Dreindl S; Wozniak P; Told R; Mylonas G; Krall C; Schmidt-Erfurth U; Sacu S
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5022-5029. PubMed ID: 28973374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of intravitreal dexamethasone implant (Ozurdex®) on retrobulbar hemodynamics in patients with diabetic macular edema and retinal vein occlusions.
    Gok M; Altas H; Kapti HB
    Cutan Ocul Toxicol; 2019 Sep; 38(3):240-248. PubMed ID: 30773934
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of Intravitreal Ranibizumab on Vessel Functionality in Patients With Retinal Vein Occlusion.
    Corvi F; La Spina C; Benatti L; Querques L; Lattanzio R; Bandello F; Querques G
    Am J Ophthalmol; 2015 Jul; 160(1):45-52.e1. PubMed ID: 25896458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of retinal vessels and retrobulbar hemodynamics to intravitreal anti-VEGF treatment in eyes with branch retinal vein occlusion.
    Sacu S; Pemp B; Weigert G; Matt G; Garhofer G; Pruente C; Schmetterer L; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3046-50. PubMed ID: 21051706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic response to intravitreal triamcinolone in eyes with macular edema: intravitreal triamcinolone and ocular blood flow.
    Cekiç O; Bardak Y; Tiğ SU; Demirkol A; Ekim MM; Altintaş O; Yeşildağ A; Oyar O
    Int Ophthalmol; 2007 Oct; 27(5):313-9. PubMed ID: 17505781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal oximetry during treatment of retinal vein occlusion by ranibizumab in patients with high blood pressure and dyslipidemia.
    Keilani C; Halalchi A; Wakpi Djeugue D; Regis A; Abada S
    J Fr Ophtalmol; 2016 Dec; 39(10):816-821. PubMed ID: 27865689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DYNAMIC AND STATIC RETINAL VESSEL ANALYSES IN PATIENTS WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION.
    Corvi F; Querques G; La Spina C; Lattanzio R; Bandello F
    Retina; 2015 Oct; 35(10):2052-9. PubMed ID: 25932556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population.
    Gu X; Yu X; Song S; Dai H
    Ophthalmic Res; 2017; 58(1):8-14. PubMed ID: 28334720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of morphological and functional changes after repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion.
    Bandello F; Parravano M; Cavallero E; Cascavilla ML; Triolo G; Querques L; Borrelli E; Giorno P; Varano M; Lattanzio R; Querques G
    Ophthalmic Res; 2015; 53(4):207-16. PubMed ID: 25896233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravitreal aflibercept (Eylea
    Gok M; Kapti HB
    Int Ophthalmol; 2018 Apr; 38(2):713-719. PubMed ID: 28421399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early effects of dexamethasone implant on macular morphology and visual function in patients with macular edema secondary to retinal vein occlusion.
    Veritti D; Macor S; Lanzetta P
    Ophthalmologica; 2014; 232(3):144-8. PubMed ID: 25300393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monthly microperimetry (MP1) measurement of macular sensitivity after dexamethasone implantation (Ozurdex) in retinal vein occlusions.
    Winterhalter S; Vom Brocke GA; Klamann MK; Müller B; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):1873-82. PubMed ID: 25576170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of retinal flow volume after intravitreal injection of bevacizumab in branch retinal vein occlusion with macular edema: a case series.
    Noma H; Yasuda K; Minezaki T; Watarai S; Shimura M
    BMC Ophthalmol; 2016 May; 16():61. PubMed ID: 27225268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomical and functional recurrence after dexamethasone intravitreal implants: a 6-month prospective study.
    Fortoul V; Denis P; Kodjikian L
    Eye (Lond); 2015 Jun; 29(6):769-75. PubMed ID: 25853447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intravitreal bevacizumab (Avastin) therapy on retrobulbar blood flow parameters in patients with neovascular age-related macular degeneration.
    Mete A; Saygili O; Mete A; Bayram M; Bekir N
    J Clin Ultrasound; 2010 Feb; 38(2):66-70. PubMed ID: 19953626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function.
    Querques G; Lattanzio R; Querques L; Triolo G; Cascavilla ML; Cavallero E; Del Turco C; Casalino G; Bandello F
    Retina; 2014 Feb; 34(2):330-41. PubMed ID: 23945638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
    Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
    Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.